Abstract
In this work, we have combined constant-pH molecular dynamics simulations and experiments to provide a quantitative analysis of pH dependent interactions between doxorubicin hydrochloride (DOX) cancer therapeutic and faceted nanodiamond (ND) nanoparticle carriers. Our study suggests that when a mixture of faceted ND and DOX is dissolved in a solvent, the pH of this solvent plays a controlling role in the adsorption of DOX molecules on the ND. We find that the binding of DOX molecules on ND occurs only at high pH and requires at least ∼10% of ND surface area to be fully titrated for binding to occur. As such, this study reveals important mechanistic insight underlying an ND-based pH-controlled therapeutic platform.
Original language | English (US) |
---|---|
Pages (from-to) | 368-374 |
Number of pages | 7 |
Journal | Molecular Pharmaceutics |
Volume | 8 |
Issue number | 2 |
DOIs | |
State | Published - Apr 4 2011 |
Funding
Keywords
- CpHMD
- adsorption
- doxorubicine
- drug delivery
- nanodiamond
ASJC Scopus subject areas
- Drug Discovery
- Molecular Medicine
- Pharmaceutical Science